Bedford Pharmacy Recalls Testosterone Cypionate Injection Due to Sterility Concerns
Bedford Pharmacy is recalling Testosterone Cypionate (Complete Formula) 200 mg/mL injections due to a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable drug, which poses a significant risk of serious injury or infection, meeting the criteria for a Severe rating.
Plain-English summary
Bedford Pharmacy, located in Bedford, New Hampshire, is recalling Testosterone Cypionate (Complete Formula) 200 mg/mL injections. The recall is being conducted because of a lack of assurance of sterility for the product.
The affected product consists of 2-vial packages with Lot # 09032015@16 and an expiration date of 10/18/2015. The recall is classified as Class II by the U.S. Food and Drug Administration.
The product was distributed in New Hampshire and Massachusetts. Consumers who have this product should contact their healthcare provider or the pharmacy for further instructions.
The recalled product
- Product
- Testosterone Cypionate (Complete Formula) 200 mg/mL, Injection, Bedford Pharmacy, 209 Route 101, Bedford, NH 03110, (603) 472-3919
- Manufacturer
- Bedford Pharmacy
- Category
- Drug — Injectable
- Affected units
- 2
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 09032015@16
- Exp 10/18/2015
Distribution
Part of a larger recall action
This product is one of 13 recalled by Bedford Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same manufacturer · Bedford Pharmacy
See all →- HighBedford Pharmacy Recalls P-P-P Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
- SevereBedford Pharmacy Recalls P-P-P Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
- SevereBedford Pharmacy Recalls P-P (COBAL) Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
- SevereBedford Pharmacy Recalls P-P (COBAL) Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
- SevereBedford Pharmacy Recalls P-P (COBAL) Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29